Comparative efficacy and safety of intravenous or subcutaneous belimumab in combination with standard therapy in patients with active systemic lupus erythematosus: a Bayesian network meta-analysis of randomized controlled trials.
作者： Y H Lee , G G Song
关键词: Meta-analysis 、 Pharmacology 、 Systemic lupus 、 Belimumab 、 Medicine 、 In patient 、 Placebo 、 Relative efficacy 、 Standard therapy 、 Internal medicine 、 Randomized controlled trial
摘要: ObjectiveIn this study, we aimed to assess the relative efficacy and safety of intravenous (IV) or subcutaneous (SC) belimumab compared with those placebo in patients active systemic lupus ...
sagepub.com
elsevier.com
sci-hub.se 参考文章(32)
Deborah M Caldwell, A E Ades, J P T Higgins, Simultaneous comparison of multiple treatments: combining direct and indirect evidence BMJ. ,vol. 331, pp. 897- 900 ,(2005) , 10.1136/BMJ.331.7521.897
Pascal Schneider, Fabienne Mackay, Fabien B. Vincent, Eric F. Morand, The BAFF/APRIL system in SLE pathogenesis Nature Reviews Rheumatology. ,vol. 10, pp. 365- 373 ,(2014) , 10.1038/NRRHEUM.2014.33
Alejandro R. Jadad, R.Andrew Moore, Dawn Carroll, Crispin Jenkinson, D.John M. Reynolds, David J. Gavaghan, Henry J. McQuay, Assessing the quality of reports of randomized clinical trials : is blinding necessary? Controlled Clinical Trials. ,vol. 17, pp. 1- 12 ,(1996) , 10.1016/0197-2456(95)00134-4
Fabienne Mackay, Stephen A. Woodcock, Pornsri Lawton, Christine Ambrose, Manfred Baetscher, Pascal Schneider, Jurg Tschopp, Jeffrey L. Browning, Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. Journal of Experimental Medicine. ,vol. 190, pp. 1697- 1710 ,(1999) , 10.1084/JEM.190.11.1697
Georgia Salanti, A.E. Ades, John P.A. Ioannidis, Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial. Journal of Clinical Epidemiology. ,vol. 64, pp. 163- 171 ,(2011) , 10.1016/J.JCLINEPI.2010.03.016
A. Vilas-Boas, S. A. Morais, D. A. Isenberg, Belimumab in systemic lupus erythematosus RMD Open. ,vol. 1, ,(2015) , 10.1136/RMDOPEN-2014-000011
Meera Ramanujam, Ramalingam Bethunaickan, Weiqing Huang, Haiou Tao, Michael P. Madaio, Anne Davidson, Selective blockade of BAFF for the prevention and treatment of systemic lupus erythematosus nephritis in NZM2410 mice Arthritis & Rheumatism. ,vol. 62, pp. 1457- 1468 ,(2010) , 10.1002/ART.27368
Kevin P. Baker, Bryan M. Edwards, Sarah H. Main, Gil H. Choi, Ruth E. Wager, Wendy G. Halpern, Patrick B. Lappin, Todd Riccobene, Donara Abramian, Les Sekut, Bonnie Sturm, Carol Poortman, Ralph R. Minter, Claire L. Dobson, Elizabeth Williams, Sara Carmen, Rodger Smith, Viktor Roschke, David M. Hilbert, Tristan J. Vaughan, Vivian R. Albert, Generation and characterization of LymphoStat-B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulator. Arthritis & Rheumatism. ,vol. 48, pp. 3253- 3265 ,(2003) , 10.1002/ART.11299
Daniel J Wallace, S Navarra, MA Petri, A Gallacher, M Thomas, R Furie, RA Levy, RF Van Vollenhoven, S Cooper, ZJ Zhong, W Freimuth, R Cervera, BLISS-52 and-76, and LBSL02 Study Groups, None, Safety profile of belimumab: pooled data from placebo-controlled phase 2 and 3 studies in patients with systemic lupus erythematosus. Lupus. ,vol. 22, pp. 144- 154 ,(2013) , 10.1177/0961203312469259
Eric S. Day, Teresa G. Cachero, Fang Qian, Yaping Sun, Dingyi Wen, Marc Pelletier, Yen-Ming Hsu, Adrian Whitty, Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA. Biochemistry. ,vol. 44, pp. 1919- 1931 ,(2005) , 10.1021/BI048227K